2019 Beyond Annual Lecture with Jennifer Doudna
Our technological capacity to make changes to genomic data has expanded exponentially since the 2012 discovery of CRISPR-Cas9 as an RNA-programmable genome editing tool.
Over the past seven years, this genome editing platform has been used to revolutionize research, develop new agricultural crops, and even promises to cure genetic diseases.
However, ethical and societal concerns abound, requiring a thoughtful and ongoing discussion among scientists and stakeholder groups.
